Cargando…
0.9% Sodium chloride solution versus Plasma-Lyte 148 versus compound sodium lacTate solution in children admitted to PICU—a randomized controlled trial (SPLYT-P): study protocol for an intravenous fluid therapy trial
BACKGROUND: Intravenous fluid therapy represents the most common intervention critically ill patients are exposed to. Hyperchloremia and metabolic acidosis associated with 0.9% sodium chloride have been observed to lead to worse outcomes, including mortality. Balanced solutions, such as Plasma-Lyte...
Autores principales: | Raman, Sainath, Schibler, Andreas, Marsney, Renate Le, Trnka, Peter, Kennedy, Melanie, Mattke, Adrian, Gibbons, Kristen, Schlapbach, Luregn J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254328/ https://www.ncbi.nlm.nih.gov/pubmed/34217337 http://dx.doi.org/10.1186/s13063-021-05376-5 |
Ejemplares similares
-
Plasma-Lyte 148 and Plasma-Lyte 148 + 5% glucose compatibility with commonly used critical care drugs
por: Hammond, Sophie, et al.
Publicado: (2020) -
Plasma-Lyte 148: A clinical review
por: Weinberg, Laurence, et al.
Publicado: (2016) -
The effects of Plasma-Lyte 148 solution on blood coagulation: an in-vitro, volunteer study using rotational thromboelastometry
por: Shin, Hyun-Jung, et al.
Publicado: (2018) -
REstrictive versus StandarD FlUid Management in Mechanically Ventilated ChildrEn Admitted to PICU: study protocol for a pilot randomised controlled trial (REDUCE-1)
por: Raman, Sainath, et al.
Publicado: (2023) -
Plasma-Lyte-148 Versus Normal Saline 0.9% in Diabetic Ketoacidosis Management: A Review
por: Othman, Mutaz I, et al.
Publicado: (2023)